When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus

Maintaining glycemic control through intensive clinical management of patients with type 2 diabetes mellitus (T2DM) is well recognized to reduce the risk of diabetes-associated complications. Patients in Russia have high rates of microvascular and macrovascular complications as a result of undiagnos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elena V. Buryukova, Abdul Jabbar, Svetlana V. Elizarova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2017
Materias:
Acceso en línea:https://doaj.org/article/7064630c00a648cdb4fccd13437a7832
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7064630c00a648cdb4fccd13437a7832
record_format dspace
spelling oai:doaj.org-article:7064630c00a648cdb4fccd13437a78322021-11-14T09:00:21ZWhen basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus2072-03512072-037810.14341/DM8824https://doaj.org/article/7064630c00a648cdb4fccd13437a78322017-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/8824https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Maintaining glycemic control through intensive clinical management of patients with type 2 diabetes mellitus (T2DM) is well recognized to reduce the risk of diabetes-associated complications. Patients in Russia have high rates of microvascular and macrovascular complications as a result of undiagnosed, untreated, or inadequately treated diabetes, emphasizing the need for better clinical management. The introduction of basal insulin therapy is often necessary for patients with T2DM when oral antihyperglycemic drugs and lifestyle management strategies are no longer effective inmaintaining glycemic targets. However, after initiation of insulin, patients often remain on basal insulin for long periods despite suboptimal glycemic control, and intensification of insulin therapy is frequently necessary. Here, we report on several different insulin intensification strategies available to clinicians and their patients to improve glycemic control and the advantages and disadvantages of each approach. These strategies include the use of short- and long-acting insulins administered either as bolus doses or as premixed insulins. When selecting the most appropriate intensification strategy, clinicians should consider the lifestyle and treatment goals of their patients to help ensure treatment success.Elena V. BuryukovaAbdul JabbarSvetlana V. ElizarovaEndocrinology Research Centrearticlediabetes mellitus, type 2insulininsulin mixturesinsulin intensificationhemoglobin aglycosylatedefficacysafetyNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 20, Iss 5, Pp 363-373 (2017)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes mellitus, type 2
insulin
insulin mixtures
insulin intensification
hemoglobin a
glycosylated
efficacy
safety
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes mellitus, type 2
insulin
insulin mixtures
insulin intensification
hemoglobin a
glycosylated
efficacy
safety
Nutritional diseases. Deficiency diseases
RC620-627
Elena V. Buryukova
Abdul Jabbar
Svetlana V. Elizarova
When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
description Maintaining glycemic control through intensive clinical management of patients with type 2 diabetes mellitus (T2DM) is well recognized to reduce the risk of diabetes-associated complications. Patients in Russia have high rates of microvascular and macrovascular complications as a result of undiagnosed, untreated, or inadequately treated diabetes, emphasizing the need for better clinical management. The introduction of basal insulin therapy is often necessary for patients with T2DM when oral antihyperglycemic drugs and lifestyle management strategies are no longer effective inmaintaining glycemic targets. However, after initiation of insulin, patients often remain on basal insulin for long periods despite suboptimal glycemic control, and intensification of insulin therapy is frequently necessary. Here, we report on several different insulin intensification strategies available to clinicians and their patients to improve glycemic control and the advantages and disadvantages of each approach. These strategies include the use of short- and long-acting insulins administered either as bolus doses or as premixed insulins. When selecting the most appropriate intensification strategy, clinicians should consider the lifestyle and treatment goals of their patients to help ensure treatment success.
format article
author Elena V. Buryukova
Abdul Jabbar
Svetlana V. Elizarova
author_facet Elena V. Buryukova
Abdul Jabbar
Svetlana V. Elizarova
author_sort Elena V. Buryukova
title When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
title_short When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
title_full When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
title_fullStr When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
title_full_unstemmed When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
title_sort when basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
publisher Endocrinology Research Centre
publishDate 2017
url https://doaj.org/article/7064630c00a648cdb4fccd13437a7832
work_keys_str_mv AT elenavburyukova whenbasalinsulinisnotenoughsuccessfulstrategiesforinsulinintensificationinpatientswithtype2diabetesmellitus
AT abduljabbar whenbasalinsulinisnotenoughsuccessfulstrategiesforinsulinintensificationinpatientswithtype2diabetesmellitus
AT svetlanavelizarova whenbasalinsulinisnotenoughsuccessfulstrategiesforinsulinintensificationinpatientswithtype2diabetesmellitus
_version_ 1718429537051607040